Nephros (NEPH) Total Current Liabilities (2010 - 2026)

Nephros' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $2.5 million for Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 66.47% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $2.5 million, a 66.47% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, up 77.14% from the prior year.
• Total Current Liabilities declined to $2.5 million in Q1 2026 per NEPH's latest filing, from $2.8 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $2.8 million in Q4 2025 and bottomed at $1.1 million in Q3 2024.
• The 5-year median for Total Current Liabilities is $1.8 million (2025), against an average of $1.8 million.
• Across the five-year window, Total Current Liabilities slumped 43.3% in 2023 and jumped 133.18% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $1.4 million in 2022, then jumped by 49.65% to $2.1 million in 2023, then declined by 26.08% to $1.6 million in 2024, then jumped by 77.14% to $2.8 million in 2025, then declined by 8.67% to $2.5 million in 2026.
• Per Business Quant, the three latest NEPH Total Current Liabilities figures stand at $2.5 million (Q1 2026), $2.8 million (Q4 2025), and $2.5 million (Q3 2025).